Drugs / Tolperisone
Tolperisone
also known as
AV650 · tolperisone HCl · Deutolperisona · N-553 FREE BASE · NSC-107321 · Tolperisona · Tolperisone Hydrochloride
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT04465266 | Jul → Aug 2020 | — | Neurana Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT04407377 | Jun → Oct 2020 | — | Neurana Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT03802565 | Feb → Jun 2019 | — | Neurana Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00532532 | Sep 2007 → Sep 2008 | — | Avigen | Terminated | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT04671082 | Dec 2020 → Dec 2021 | — | Neurana Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT05544656 | Dec 2019 → Dec 2023 | — | Semmelweis University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00531466 Comparator | Sep 2007 → Nov 2008 | — | Avigen | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05223946 Background | Sep 2020 → May 2021 | — | Kyrgyz State Medical Academy | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tolperisone | “ketoprofen, tolperisone, symptomatic slow-acting drugs in osteoarthritis - SYSADOA - (glucosamine + chondroitin sulfate )” NCT05223946 ↗ |
| Known as | AV650 | “A drug called AV650 (tolperisone HCl) will be given to patients who have spasticity associated with multiple sclerosis.” NCT00532532 ↗1“A drug called AV650 (tolperisone HCl) will be given to patients who have spasticity following a spinal cord injury.” NCT00531466 ↗ |
| Known as | Deutolperisona | ChEMBL registry synonym — accepted as the source's own label CHEMBL1076211 ↗ |
| Known as | N-553 FREE BASE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1076211 ↗ |
| Known as | NSC-107321 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1076211 ↗ |
| Known as | Tolperisona | ChEMBL registry synonym — accepted as the source's own label CHEMBL1076211 ↗ |
| Known as | tolperisone HCl | “A drug called AV650 (tolperisone HCl) will be given to patients who have spasticity associated with multiple sclerosis.” NCT00532532 ↗1“A drug called AV650 (tolperisone HCl) will be given to patients who have spasticity following a spinal cord injury.” NCT00531466 ↗ |
| Known as | Tolperisone Hydrochloride | “Tolperisone Hydrochloride tablets of 150 mg, administered three times a day” NCT05544656 ↗ |
| Modality | Small molecule | — CHEMBL1076211 ↗ |
| Route | Oral | “One tablet orally three times a day for 28 days” NCT00531466 ↗ |